Skip to main content
Equibles

MORGAN STANLEY

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,752,354
+$318,353 QoQ
Shares Held
982,307
+0.5% QoQ
Ownership
1.59%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 46% Shared 0% None 54%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. KYTX ranks #146 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in KYTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,752,354 982,307
2026-03-31 $8,434,001 977,289
2025-12-31 $9,423,451 1,002,495
2025-09-30 $1,045,218 174,203
2025-06-30 $620,253 202,038
2025-03-31 $260,373 134,910
2024-12-31 $750,219 200,594
2024-09-30 $585,788 119,794
2024-06-30 $894,622 119,283
2024-03-31 $991,883 39,931